Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

7.17
Data as of 3:59pm ET
 -0.12 / -1.65%
Today’s Change
2.05
Today|||52-Week Range
8.25
+34.50%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$762.4M

Company Description

Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. It applies a systems biology-based approach to biomedical research, throughout the research and development process. Merrimack Pharmaceuticals was founded by Anthony J. Sinskey, Gavin MacBeath and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.

Contact Information

Merrimack Pharmaceuticals, Inc.
One Kendall Square
Cambridge Massachusetts 02139
P:(617) 441-1000
Investor Relations:
(617) 441-7602

Employees

Shareholders

Individual stakeholders8.27%
Mutual fund holders34.90%
Other institutional18.96%

Top Executives

Robert J. MulroyPresident, Chief Executive Officer & Director
William M. McClementsSenior Vice President-Operations
William A. SullivanChief Financial Officer & Treasurer
Ulrik B. NielsenChief Scientific Officer & Senior Vice President
Edward J. StewartSenior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.